Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Cohen

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Current Opinion in HIV and AIDS|January 5, 2010
Management of individuals requiring antiretroviral therapy and TB treatmentKaren Cohen, Graeme Meintjes
Expert Opinion on Drug Safety|July 25, 2019
A safety evaluation of bedaquiline for the treatment of multi-drug resistant tuberculosisKaren Cohen, Gary Maartens
Pain|October 1, 1982
Effects of a directive return to work approach in the treatment of workman's compensation patients with chronic painRichard Catchlove, Karen Cohen
The Lancet. HIV|October 12, 2019
Transition to third-line ART in resource-limited settingsKaren Cohen, Catherine J Orrell
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 17, 2011
The prevalence of hepatitis B infection in a rural South African HIV clinicTom H Boyles, Karen Cohen
Southern African Journal of HIV Medicine|June 18, 2019
The role of rilpivirine in Southern AfricaMichelle A Moorhouse, Karen Cohen
Antiviral Therapy|December 25, 2009
Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countriesGary Maartens, Eric Decloedt, Karen Cohen
Plos One|June 1, 2013
Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reactionReneé de Waal, Karen Cohen, Gary Maartens
Southern African Journal of Infectious Diseases|May 13, 2025
Cefepime-induced neurotoxicityJessica Taylor, Hannah M Gunter, Karen Cohen
Expert Review of Clinical Pharmacology|August 9, 2016
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimenJohannes P Mouton, Karen Cohen, Gary Maartens
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Opinion in HIV and AIDS|January 5, 2010
Management of individuals requiring antiretroviral therapy and TB treatmentKaren Cohen, Graeme Meintjes
Expert Opinion on Drug Safety|July 25, 2019
A safety evaluation of bedaquiline for the treatment of multi-drug resistant tuberculosisKaren Cohen, Gary Maartens
Pain|October 1, 1982
Effects of a directive return to work approach in the treatment of workman's compensation patients with chronic painRichard Catchlove, Karen Cohen
The Lancet. HIV|October 12, 2019
Transition to third-line ART in resource-limited settingsKaren Cohen, Catherine J Orrell
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 17, 2011
The prevalence of hepatitis B infection in a rural South African HIV clinicTom H Boyles, Karen Cohen
Southern African Journal of HIV Medicine|June 18, 2019
The role of rilpivirine in Southern AfricaMichelle A Moorhouse, Karen Cohen
Antiviral Therapy|December 25, 2009
Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countriesGary Maartens, Eric Decloedt, Karen Cohen
Plos One|June 1, 2013
Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reactionReneé de Waal, Karen Cohen, Gary Maartens
Southern African Journal of Infectious Diseases|May 13, 2025
Cefepime-induced neurotoxicityJessica Taylor, Hannah M Gunter, Karen Cohen
Expert Review of Clinical Pharmacology|August 9, 2016
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimenJohannes P Mouton, Karen Cohen, Gary Maartens
Pageof 10